Dr. Mary L. Zupanc discusses why she’s passionate about preventing patients transitioning to adult care from falling through the cracks.
In the spotlight: Dr. Suresh Magge
The new co-medical director of the CHOC Neuroscience Institute and neurosurgery medical director takes a personalized approach to care.
Wired for hope: deep brain stimulation for dystonia
A first for CHOC, a team led by Dr. Terence Sanger and Dr. Joffre Olaya treats a teen’s movement disorder through deep brain stimulation.
Investigational Drug Study Leads to FDA Approval for Fenfluramine in Treatment for Dravet Syndrome
Dr. Mary Zupanc was a key investigator in a study that led to FDA approval for a medication to treat children with Dravet syndrome.
Leading-edge biomarker research aids in infantile spasms management
Much of infantile spasms research focuses on visual analysis of a patient’s EEG, whereas Dr. Daniel Shrey’s research uses a computation.
CHOC pioneers medical home for children with autism
The Thompson Autism and Neurodevelopmental Center addresses autism defined core symptoms through a medical home approach that reduces unmet healthcare needs.
